位置:首页 > 蛋白库 > POLG_RHDVF
POLG_RHDVF
ID   POLG_RHDVF              Reviewed;        2344 AA.
AC   P27410;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   03-AUG-2022, entry version 141.
DE   RecName: Full=Genome polyprotein;
DE   AltName: Full=p254;
DE   Contains:
DE     RecName: Full=Protein p16;
DE   Contains:
DE     RecName: Full=Protein p23;
DE   Contains:
DE     RecName: Full=NTPase;
DE              EC=3.6.1.15;
DE     AltName: Full=2C-like protein;
DE     AltName: Full=P2C;
DE     AltName: Full=p37;
DE   Contains:
DE     RecName: Full=Precursor p41;
DE   Contains:
DE     RecName: Full=Protein p29;
DE   Contains:
DE     RecName: Full=Protein p23/2;
DE   Contains:
DE     RecName: Full=Protein p18;
DE   Contains:
DE     RecName: Full=Viral genome-linked protein;
DE     AltName: Full=VPg;
DE     AltName: Full=p13;
DE   Contains:
DE     RecName: Full=3C-like protease;
DE              Short=3CLpro;
DE              EC=3.4.22.66;
DE     AltName: Full=Calicivirin;
DE     AltName: Full=Thiol protease P3C;
DE     AltName: Full=p15;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase;
DE              EC=2.7.7.48;
DE     AltName: Full=3Dpol;
DE     AltName: Full=p58;
DE   Contains:
DE     RecName: Full=Capsid protein VP60;
GN   ORFNames=ORF1;
OS   Rabbit hemorrhagic disease virus (strain Rabbit/Germany/FRG/1989)
OS   (Ra/LV/RHDV/GH/1989/GE) (RHDV-FRG).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Picornavirales; Caliciviridae; Lagovirus.
OX   NCBI_TaxID=314536;
OH   NCBI_TaxID=9986; Oryctolagus cuniculus (Rabbit).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=1840711; DOI=10.1016/0042-6822(91)90436-f;
RA   Meyers G., Wirblich C., Thiel H.-J.;
RT   "Rabbit hemorrhagic disease virus -- molecular cloning and nucleotide
RT   sequencing of a calicivirus genome.";
RL   Virology 184:664-676(1991).
RN   [2]
RP   FUNCTION OF VPG.
RX   PubMed=1887589; DOI=10.1016/0042-6822(91)90437-g;
RA   Meyers G., Wirblich C., Thiel H.-J.;
RT   "Genomic and subgenomic RNAs of rabbit hemorrhagic disease virus are both
RT   protein-linked and packaged into particles.";
RL   Virology 184:677-686(1991).
RN   [3]
RP   MUTAGENESIS OF HIS-1135; ASP-1152; ASP-1175; CYS-1212 AND HIS-1227.
RX   PubMed=8083986; DOI=10.1128/jvi.68.10.6487-6495.1994;
RA   Boniotti B., Wirblich C., Sibilia M., Meyers G., Thiel H.J., Rossi C.;
RT   "Identification and characterization of a 3C-like protease from rabbit
RT   hemorrhagic disease virus, a calicivirus.";
RL   J. Virol. 68:6487-6495(1994).
RN   [4]
RP   PROTEOLYTIC PROCESSING OF POLYPROTEIN.
RX   PubMed=7474137; DOI=10.1128/jvi.69.11.7159-7168.1995;
RA   Wirblich C., Sibilia M., Boniotti M.B., Rossi C., Thiel H.-J., Meyers G.;
RT   "3C-like protease of rabbit hemorrhagic disease virus: identification of
RT   cleavage sites in the ORF1 polyprotein and analysis of cleavage
RT   specificity.";
RL   J. Virol. 69:7159-7168(1995).
RN   [5]
RP   SUBGENOMIC ORIGIN OF VP60.
RX   PubMed=7637026; DOI=10.1128/jvi.69.9.5812-5815.1995;
RA   Sibilia M., Boniotti M.B., Angoscini P., Capucci L., Rossi C.;
RT   "Two independent pathways of expression lead to self-assembly of the rabbit
RT   hemorrhagic disease virus capsid protein.";
RL   J. Virol. 69:5812-5815(1995).
RN   [6]
RP   PROTEOLYTIC PROCESSING OF POLYPROTEIN.
RX   PubMed=9557747; DOI=10.1128/jvi.72.5.4492-4497.1998;
RA   Konig M., Thiel H.J., Meyers G.;
RT   "Detection of viral proteins after infection of cultured hepatocytes with
RT   rabbit hemorrhagic disease virus.";
RL   J. Virol. 72:4492-4497(1998).
RN   [7]
RP   PROTEOLYTIC PROCESSING OF POLYPROTEIN.
RX   PubMed=11040126; DOI=10.1006/viro.2000.0545;
RA   Meyers G., Wirblich C., Thiel H.J., Thumfart J.O.;
RT   "Rabbit hemorrhagic disease virus: genome organization and polyprotein
RT   processing of a calicivirus studied after transient expression of cDNA
RT   constructs.";
RL   Virology 276:349-363(2000).
RN   [8]
RP   PROTEOLYTIC PROCESSING OF POLYPROTEIN.
RX   PubMed=10644847; DOI=10.1099/0022-1317-81-2-481;
RA   Joubert P., Pautigny C., Madelaine M.-F., Rasschaert D.;
RT   "Identification of a new cleavage site of the 3C-like protease of rabbit
RT   haemorrhagic disease virus.";
RL   J. Gen. Virol. 81:481-488(2000).
RN   [9]
RP   CHARACTERIZATION OF RNA-DIRECTED RNA POLYMERASE.
RX   PubMed=11266218; DOI=10.1007/s007050170191;
RA   Lopez Vazquez A.L., Martin Alonso J.M., Parra F.;
RT   "Characterisation of the RNA-dependent RNA polymerase from Rabbit
RT   hemorrhagic disease virus produced in Escherichia coli.";
RL   Arch. Virol. 146:59-69(2001).
RN   [10]
RP   PROTEOLYTIC PROCESSING OF POLYPROTEIN.
RX   PubMed=12504575; DOI=10.1006/viro.2002.1660;
RA   Thumfart J.O., Meyers G.;
RT   "Rabbit hemorrhagic disease virus: identification of a cleavage site in the
RT   viral polyprotein that is not processed by the known calicivirus
RT   protease.";
RL   Virology 304:352-363(2002).
RN   [11]
RP   FUNCTION OF CAPSID PROTEIN VP60.
RX   PubMed=15063122; DOI=10.1016/j.virol.2004.01.021;
RA   Barcena J., Verdaguer N., Roca R., Morales M., Angulo I., Risco C.,
RA   Carrascosa J.L., Torres J.M., Caston J.R.;
RT   "The coat protein of Rabbit hemorrhagic disease virus contains a molecular
RT   switch at the N-terminal region facing the inner surface of the capsid.";
RL   Virology 322:118-134(2004).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1252-1767.
RX   PubMed=11677245; DOI=10.1074/jbc.m109261200;
RA   Ng K.K.S., Cherney M.M., Vazquez A.L., Machin A., Martin-Alonso J.M.,
RA   Parra F., James M.N.G.;
RT   "Crystal structures of active and inactive conformations of a caliciviral
RT   RNA-dependent RNA polymerase.";
RL   J. Biol. Chem. 277:1381-1387(2002).
CC   -!- FUNCTION: NTPase presumably plays a role in replication. {ECO:0000250}.
CC   -!- FUNCTION: Viral genome-linked protein is covalently linked to the 5'-
CC       end of the positive-strand, negative-strand genomic RNAs and subgenomic
CC       RNA. Acts as a genome-linked replication primer. May recruit ribosome
CC       to viral RNA thereby promoting viral proteins translation (By
CC       similarity). {ECO:0000250}.
CC   -!- FUNCTION: 3C-like protease processes the polyprotein: 3CLpro-RdRp (p72)
CC       is first released by autocleavage, then all other proteins are cleaved.
CC       {ECO:0000250}.
CC   -!- FUNCTION: RNA-directed RNA polymerase replicates genomic and
CC       antigenomic RNA by recognizing replications specific signals.
CC       Transcribes also a subgenomic mRNA by initiating RNA synthesis
CC       internally on antigenomic RNA. This sgRNA codes for structural
CC       proteins. Catalyzes the covalent attachment VPg with viral RNAs (By
CC       similarity). {ECO:0000255|PROSITE-ProRule:PRU00539}.
CC   -!- FUNCTION: Capsid protein VP60 self assembles to form an icosahedral
CC       capsid with a T=3 symmetry, about 35 nm in diameter, and consisting of
CC       180 capsid proteins. A smaller form of capsid with a diameter of 23 nm
CC       might be capsid proteins assembled as icosahedron with T=1 symmetry.
CC       The capsid encapsulate VP2 proteins and genomic or subgenomic RNA.
CC       Attaches virion to target cells by binding histo-blood group antigens,
CC       inducing endocytosis of the viral particle. Acidification of the
CC       endosome induces conformational change of capsid protein thereby
CC       injecting virus genomic RNA into host cytoplasm (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'-
CC         diphosphate + H(+) + phosphate; Xref=Rhea:RHEA:23680,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57930, ChEBI:CHEBI:61557; EC=3.6.1.15;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ribonucleoside 5'-triphosphate + RNA(n) = diphosphate +
CC         RNA(n+1); Xref=Rhea:RHEA:21248, Rhea:RHEA-COMP:14527, Rhea:RHEA-
CC         COMP:17342, ChEBI:CHEBI:33019, ChEBI:CHEBI:61557, ChEBI:CHEBI:140395;
CC         EC=2.7.7.48; Evidence={ECO:0000255|PROSITE-ProRule:PRU00539};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Endopeptidase with a preference for cleavage when the P1
CC         position is occupied by Glu-|-Xaa and the P1' position is occupied by
CC         Gly-|-Yaa.; EC=3.4.22.66; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU01242};
CC   -!- SUBUNIT: Binds to histo-blood group antigens at surface of target
CC       cells. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Capsid protein VP60]: Virion. Host cytoplasm
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage; Named isoforms=2;
CC       Name=Genome polyprotein;
CC         IsoId=P27410-1; Sequence=Displayed;
CC       Name=Subgenomic capsid protein VP60; Synonyms=VP1;
CC         IsoId=P27410-2; Sequence=VSP_034381;
CC   -!- PTM: Specific enzymatic cleavages by its own cysteine protease yield
CC       mature proteins. The protease cleaves itself from the nascent
CC       polyprotein autocatalytically. Precursor p41 can be cleaved by viral
CC       3CLpro into protein p19 and VPg, or cleaved by host protease into
CC       protein p23/2 and protein p18. {ECO:0000269|PubMed:10644847,
CC       ECO:0000269|PubMed:11040126, ECO:0000269|PubMed:12504575,
CC       ECO:0000269|PubMed:7474137, ECO:0000269|PubMed:9557747}.
CC   -!- PTM: VPg is uridylylated by the polymerase and is covalently attached
CC       to the 5'-end of the polyadenylated genomic and subgenomic RNAs. This
CC       uridylylated form acts as a nucleotide-peptide primer for the
CC       polymerase (By similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: Two different RNAs lead the expression of the capsid
CC       protein. One arises from the cleavage of the polyprotein translated
CC       from the genomic RNA and the other from the translation of a subgenomic
CC       RNA derived from the (-)RNA template. Capsid protein expressed from the
CC       subgenomic mRNA is produced in much larger amounts than the cleaved one
CC       (By similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform Genome polyprotein]: Produced from the genomic
CC       RNA.
CC   -!- MISCELLANEOUS: [Isoform Subgenomic capsid protein VP60]: Produced from
CC       the subgenomic RNA. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M67473; AAA47285.1; -; Genomic_RNA.
DR   PIR; A41039; RRWWRH.
DR   RefSeq; NP_062875.1; NC_001543.1.
DR   PDB; 1KHV; X-ray; 2.50 A; A/B=1252-1767.
DR   PDB; 1KHW; X-ray; 2.70 A; A/B=1252-1767.
DR   PDB; 6M24; X-ray; 2.29 A; C=2271-2279.
DR   PDB; 6M2J; X-ray; 2.20 A; C=2308-2316.
DR   PDB; 6M2K; X-ray; 2.59 A; C=2106-2114.
DR   PDBsum; 1KHV; -.
DR   PDBsum; 1KHW; -.
DR   PDBsum; 6M24; -.
DR   PDBsum; 6M2J; -.
DR   PDBsum; 6M2K; -.
DR   SMR; P27410; -.
DR   MEROPS; C24.001; -.
DR   PRIDE; P27410; -.
DR   GeneID; 1491968; -.
DR   KEGG; vg:1491968; -.
DR   BRENDA; 3.4.22.B15; 5265.
DR   EvolutionaryTrace; P27410; -.
DR   Proteomes; UP000000413; Genome.
DR   GO; GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0019028; C:viral capsid; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0017111; F:nucleoside-triphosphatase activity; IEA:RHEA.
DR   GO; GO:0003723; F:RNA binding; IEA:InterPro.
DR   GO; GO:0003724; F:RNA helicase activity; IEA:InterPro.
DR   GO; GO:0003968; F:RNA-directed 5'-3' RNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   GO; GO:0018144; P:RNA-protein covalent cross-linking; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0039694; P:viral RNA genome replication; IEA:InterPro.
DR   CDD; cd00205; rhv_like; 1.
DR   Gene3D; 2.60.120.20; -; 1.
DR   Gene3D; 3.30.70.270; -; 1.
DR   Gene3D; 3.40.50.300; -; 1.
DR   InterPro; IPR004005; Calicivirus_coat.
DR   InterPro; IPR043502; DNA/RNA_pol_sf.
DR   InterPro; IPR004004; Helic/Pol/Pept_Calicivir-typ.
DR   InterPro; IPR000605; Helicase_SF3_ssDNA/RNA_vir.
DR   InterPro; IPR014759; Helicase_SF3_ssRNA_vir.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000317; Peptidase_C24.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR043128; Rev_trsase/Diguanyl_cyclase.
DR   InterPro; IPR033703; Rhv-like.
DR   InterPro; IPR001205; RNA-dir_pol_C.
DR   InterPro; IPR007094; RNA-dir_pol_PSvirus.
DR   InterPro; IPR029053; Viral_coat.
DR   Pfam; PF00915; Calici_coat; 1.
DR   Pfam; PF03510; Peptidase_C24; 1.
DR   Pfam; PF00680; RdRP_1; 1.
DR   Pfam; PF00910; RNA_helicase; 1.
DR   PRINTS; PR00916; 2CENDOPTASE.
DR   PRINTS; PR00918; CALICVIRUSNS.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF56672; SSF56672; 1.
DR   PROSITE; PS51894; CV_3CL_PRO; 1.
DR   PROSITE; PS50507; RDRP_SSRNA_POS; 1.
DR   PROSITE; PS51218; SF3_HELICASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative promoter usage; ATP-binding; Capsid protein;
KW   Covalent protein-RNA linkage; Disulfide bond; Helicase; Host cytoplasm;
KW   Hydrolase; Nucleotide-binding; Nucleotidyltransferase; Phosphoprotein;
KW   Protease; Reference proteome; RNA-directed RNA polymerase; Thiol protease;
KW   Transferase; Viral RNA replication; Virion.
FT   CHAIN           1..2344
FT                   /note="Genome polyprotein"
FT                   /id="PRO_0000341645"
FT   CHAIN           1..143
FT                   /note="Protein p16"
FT                   /id="PRO_0000036959"
FT   CHAIN           144..339
FT                   /note="Protein p23"
FT                   /id="PRO_0000036960"
FT   CHAIN           340..718
FT                   /note="NTPase"
FT                   /id="PRO_0000036961"
FT   CHAIN           719..1108
FT                   /note="Precursor p41"
FT                   /id="PRO_0000341646"
FT   CHAIN           719..993
FT                   /note="Protein p29"
FT                   /id="PRO_0000036962"
FT   CHAIN           719..936
FT                   /note="Protein p23/2"
FT                   /id="PRO_0000341647"
FT   CHAIN           937..1108
FT                   /note="Protein p18"
FT                   /id="PRO_0000341648"
FT   CHAIN           994..1108
FT                   /note="Viral genome-linked protein"
FT                   /id="PRO_0000036963"
FT   CHAIN           1109..1251
FT                   /note="3C-like protease"
FT                   /id="PRO_0000036964"
FT   CHAIN           1252..1767
FT                   /note="RNA-directed RNA polymerase"
FT                   /id="PRO_0000036965"
FT   CHAIN           1768..2344
FT                   /note="Capsid protein VP60"
FT                   /id="PRO_0000036967"
FT   DOMAIN          492..653
FT                   /note="SF3 helicase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00551"
FT   DOMAIN          1109..1244
FT                   /note="Peptidase C24"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01242"
FT   DOMAIN          1495..1619
FT                   /note="RdRp catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00539"
FT   REGION          1770..1796
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        1135
FT                   /note="For 3CLpro activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01242"
FT   ACT_SITE        1152
FT                   /note="For 3CLpro activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01242"
FT   ACT_SITE        1212
FT                   /note="For 3CLpro activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01242"
FT   BINDING         522..529
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00551"
FT   SITE            143..144
FT                   /note="Cleavage; by 3CLpro"
FT   SITE            339..340
FT                   /note="Cleavage; by 3CLpro"
FT   SITE            718..719
FT                   /note="Cleavage; by 3CLpro"
FT   SITE            936..937
FT                   /note="Cleavage; by host"
FT   SITE            993..994
FT                   /note="Cleavage; by 3CLpro"
FT   SITE            1108..1109
FT                   /note="Cleavage; by 3CLpro"
FT   SITE            1251..1252
FT                   /note="Cleavage; by 3CLpro"
FT   SITE            1767..1768
FT                   /note="Cleavage; by 3CLpro"
FT   MOD_RES         1014
FT                   /note="O-(5'-phospho-RNA)-tyrosine"
FT                   /evidence="ECO:0000250"
FT   DISULFID        1584..1591
FT   VAR_SEQ         1..1765
FT                   /note="Missing (in isoform Subgenomic capsid protein VP60)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_034381"
FT   MUTAGEN         1135
FT                   /note="H->N: Complete loss of 3CLpro activity in vitro."
FT                   /evidence="ECO:0000269|PubMed:8083986"
FT   MUTAGEN         1152
FT                   /note="D->E: Partial loss of 3CLpro activity in vitro."
FT                   /evidence="ECO:0000269|PubMed:8083986"
FT   MUTAGEN         1152
FT                   /note="D->G,N: Complete loss of 3CLpro activity in vitro."
FT                   /evidence="ECO:0000269|PubMed:8083986"
FT   MUTAGEN         1175
FT                   /note="D->G,E: Complete loss of 3CLpro activity in vitro."
FT                   /evidence="ECO:0000269|PubMed:8083986"
FT   MUTAGEN         1175
FT                   /note="D->N: Partial loss of 3CLpro activity in vitro."
FT                   /evidence="ECO:0000269|PubMed:8083986"
FT   MUTAGEN         1212
FT                   /note="C->G: Complete loss of 3CLpro activity in vitro."
FT                   /evidence="ECO:0000269|PubMed:8083986"
FT   MUTAGEN         1212
FT                   /note="C->S: Partial loss of 3CLpro activity in vitro."
FT                   /evidence="ECO:0000269|PubMed:8083986"
FT   MUTAGEN         1227
FT                   /note="H->L,N: Complete loss of 3CLpro activity in vitro."
FT                   /evidence="ECO:0000269|PubMed:8083986"
FT   STRAND          1257..1263
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1266..1271
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1282..1287
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1293..1295
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1300..1302
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1305..1307
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1315..1324
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1325..1327
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1337..1353
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   TURN            1354..1356
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1364..1370
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1373..1376
FT                   /evidence="ECO:0007829|PDB:1KHW"
FT   STRAND          1379..1381
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1385..1387
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1391..1393
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1396..1410
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1418..1423
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1440..1444
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1446..1465
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   TURN            1466..1469
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1470..1472
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1482..1493
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1495..1502
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1505..1508
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1511..1522
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1529..1539
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1543..1545
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1547..1551
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1564..1586
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1594..1597
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1600..1603
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1606..1611
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1613..1617
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1619..1628
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1633..1637
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1647..1649
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1655..1660
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1663..1668
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1670..1678
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   STRAND          1679..1689
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1698..1712
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1716..1729
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   TURN            1730..1732
FT                   /evidence="ECO:0007829|PDB:1KHV"
FT   HELIX           1740..1750
FT                   /evidence="ECO:0007829|PDB:1KHV"
SQ   SEQUENCE   2344 AA;  257068 MW;  1454C248F81E9212 CRC64;
     MAAMSRLTGM TTAILPEKKP LDFFLDLRDK TPPCCIRATG RLAWPVFPGQ NGKEGPLETC
     NKCGKWLNGF GNFGLEDLGD VCLCSIAQQK HKFGPVCLCN RVYIHDCGRW RRRSRFLKHY
     KALNKVIPCA YQFDESFPTP IFEGEVDDLF VELGAPTSMG FMDKKLLKKG KKLMDKFVDV
     DEPCLTSRDT SLLDSIASDN TIRAKLEEEY GVEMVQAARD RKDFMKNLRL ALDNRPANPV
     TWYTKLGNIT EKGKQWAKKV VYGARKVTDP LKTLASILLV GLHNVIAVDT TVMLSTFKPV
     NLLAILMDWN NDLTGFITTL VRLLELYGVV QATVNLIIEG VKSFWDKVVC ATDRCFDLLK
     RLFDTFEDSV PTGPTAGCLI FMAFVFSTVV GYLPNNSVIT TFMKGAGKLT TFAGVVGAIR
     TLWITINQHM VAKDLTSVQQ KVMTVVKMAN EAATLDQLEI VSCLCSDLET TLTNRCTLPS
     YNQHLGILNA SQKVISDLHT MVLGKINMTK QRPQPVAVIF KGAPGIGKTY LVHRIARDLG
     CQHPSTINFG LDHFDSYTGE EVAIADEFNT CGDGESWVEL FIQMVNTNPC PLNCDKAENK
     NKVFNSKYLL CTTNSNMILN ATHPRAGAFY RRVMIVEARN KAVESWQATR HGSKPGKSCY
     SKDMSHLTFQ VYPHNMPAPG FVFVGDKLVK SQVTPREYKY SELLDLIKSE HPDVASFEGA
     NKFNFVYPDA QYDQALLMWK QYFVMYGCVA RLAKNFVDDI PYNQVHISRA SDPKIEGCVE
     YQCKFQHLWR MVPQFVLGCV NMTNQLGTPL TQQQLDRITN GVEGVTVTTV NNILPFHSQT
     TLINPSFIKL IWAVRKHLKG LSGVTKVAQF IWRVMTNPVD AYGTLVRTLT GAATFSDDPV
     STTIICSNCT IQLHSCGGLL VRYSRDPVPV ASDNVDRGDQ GVDVFTDPNL ISGFSWRQIA
     HLFVEVISHL CANHLVNLAT MAALGAVATK AFQGVKGKTK RGRGARVNLG NDEYDEWQAA
     RREFVNAHDM TAEEYLAMKN KAAMGSDDQD SIMFRSWWTR RQLRPEEDQV TIVGRSGVRN
     EVIRTRVRQT PRGPKTLDDG GFYDNDYEGL PGFMRHNGSG WMIHIGNGLY ISNTHTARSS
     CSEIVTCSPT TDLCLVKGES IRSVAQIAEG TPVCDWKKSP ISTYGIKKTL SDSTKIDVLA
     YDGCTQTTHG DCGLPLYDSS GKIVAIHTGK LLGFSKMCTL IDLTITKGVY ETSNFFCGEP
     IDYRGITAHR LVGAEPRPPV SGTRYAKVPG VPDEYKTGYR PANLGRSDPD SDKSLMNIAV
     KNLQVYQQEP KLDKVDEFIE RAAADVLGYL RFLTKGERQA NLNFKAAFNT LDLSTSCGPF
     VPGKKIDHVK DGVMDQVLAK HLYKCWSVAN SGKALHHIYA CGLKDELRPL DKVKEGKKRL
     LWGCDVGVAV CAAAVFHNIC YKLKMVARFG PIAVGVDMTS RDVDVIINNL TSKASDFLCL
     DYSKWDSTMS PCVVRLAIDI LADCCEQTEL TKSVVLTLKS HPMTILDAMI VQTKRGLPSG
     MPFTSVINSI CHWLLWSAAV YKSCAEIGLH CSNLYEDAPF YTYGDDGVYA MTPMMVSLLP
     AIIENLRDYG LSPTAADKTE FIDVCPLNKI SFLKRTFELT DIGWVSKLDK SSILRQLEWS
     KTTSRHMVIE ETYDLAKEER GVQLEELQVA AAAHGQEFFN FVCRELERQQ AYTQFSVYSY
     DAARKILADR KRVVSVVPDD EFVNVMEGKA RAAPQGEAAG TATTASVPGT TTDGMDPGVV
     ATTSVITAEN SSASIATAGI GGPPQQVDQQ ETWRTNFYYN DVFTWSVADA PGSILYTVQH
     SPQNNPFTAV LSQMYAGWAG GMQFRFIVAG SGVFGGRLVR AVIPPGIEIG PGLEVRQFPH
     VVIDARSLEP VTITMPDLRP NMYHPTGDPG LVPTLVLSVY NNLINPFGGS TSAIQVTVET
     RPSEDFEFVM IRAPSSKTVD SISPAGLLTT PVLTGVGNDN RWNGQIVGLQ PVPGGFSTCN
     RHWNLNGSTY GWSSPRFGDI DHRRGSASYS GSNATNVLQF WYANAGSAID NPISQVAPDG
     FPDMSFVPFN GPGIPAAGWV GFGAIWNSNS GAPNVTTVQA YELGFATGAP GNLQPTTNTS
     GAQTVAKSIY AVVTGTAQNP AGLFVMASGI ISTPNASAIT YTPQPDRIVT TPGTPAAAPV
     GKNTPIMFAS VVRRTGDVNA TAGSANGTQY GTGSQPLPVT IGLSLNNYSS ALMPGQFFVW
     QLTFASGFME IGLSVDGYFY AGTGASTTLI DLTELIDVRP VGPRPSKSTL VFNLGGTANG
     FSYV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024